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Potential benefits that may be derived from
biotechnologies involving genetically modi-
ﬁed organisms could be enormous. Potential
risks of allergenicity possibly associated with
their use will likely be manageable, provided
appropriate information is available to de-
cision makers. At the end of the workshop
“Assessment of the Allergenic Potential of
Genetically Modified Foods,” speakers and
participants met in small groups to discuss
information needs. Five groups considered
the following key issues: a) use of human
clinical data, b) animal models to assess food
allergy, c) biomarkers of exposure and effect,
d) sensitive populations, e) dose–response
assessment, and f) postmarket surveillance.
The groups were asked to consider two gen-
eral questions: On the basis of current infor-
mation, what can we do to assess the potential
allergenicity of genetically modiﬁed food, and
what do we need to know to improve this
process, i.e., what are the most critical
research needs? The ﬁrst question is the topic
discussed in another article in this mini-
monograph (Germolec et al. 2003). The
research needs are the topic of this article.
Just as research provided the tools to generate
genetically modiﬁed food, it can also provide
the tools needed for effective safety evaluation
and risk assessment/management.
Regulatory problems are rarely stated in
scientific terms. The problem in this case is
we wish to avoid inadvertently introducing
an allergenic protein into the food supply.
One task for this workshop was to translate
this problem into research needs. Because
there is a sense of urgency to develop tools
for hazard identification, much of the con-
versation revolved around the short-term
research required to develop test methods
for this purpose. This discussion focused
largely on the potential allergens and how to
distinguish these from other proteins.
However, it was recognized also that more
long-term (basic) research is needed on the
characteristics of food allergens, allergic dis-
ease, and the mechanisms underlying sus-
ceptibility to food allergy. This discussion
considered more broadly the factors leading
to allergic sensitization, including the nature
of the allergen, and how genetics, life stage,
and other environmental influences might
affect susceptibility.
Hazard Identiﬁcation:
Immediate Needs
Research needed to improve hazard identiﬁ-
cation fell into three categories: development
of animal models, identiﬁcation and charac-
terization of food allergens, and establish-
ment of well-defined clinical serum banks.
All were deemed important to improve the
Food and Agriculture Organization of the
United Nations/World Health Organization
(FAO/WHO) decision tree (FAO/WHO
2001) or to replace it with a better approach.
Also discussed was the need to improve
human skin test technology for incorpora-
tion in a decision tree. Animal models are
needed that could be used not only for haz-
ard identiﬁcation purposes but also to deter-
mine relative potency, to derive sensitization
and elicitation thresholds, and to define the
conditions under which tolerance (failure to
develop an allergic response to potential food
allergens) is induced. Identification, charac-
terization, puriﬁcation, and banking of food
allergens (and nonallergens) are needed for
two reasons: to provide positive (and nega-
tive) controls for animal and serum bank
tests and for use in defining the characteris-
tics that confer on food proteins the ability
to induce allergic sensitization, that is, to
establish structure–activity relationships.
Serum from clinically well-defined allergic
individuals needs to be banked for use in
screening proteins of unknown allergenicity.
Development of proteomic approaches to
screen potential allergens (specific IgE on a
chip) was also suggested as a research need.
Characterization of allergens and develop-
ment of serum banks require a systematic
process for recording adverse events and
obtaining informed consent for use of serum
obtained in epidemiologic and experimental
studies. Once developed, all tests for hazard
identification will require standardization
and validation—no small task. These research
needs are summarized in Table 1.
Basic Mechanistic Research
Appropriate animal models (not necessarily
the same as those used for hazard identiﬁca-
tion) and human clinical and epidemiologic
studies are needed to assess the correlation
between antigen-speciﬁc IgE and clinical dis-
ease and to investigate the influence of the
route, duration, and nature of exposure on
the development of sensitization. An impor-
tant research need is to investigate the mecha-
nisms underlying food allergy, including the
development of and failure to develop oral
tolerance, and identiﬁcation of possible win-
dows of vulnerability during immune devel-
opment (including in utero and during
lactation) or unique exposure conditions that
might place children at greater risk. The
mechanisms underlying the development of
tolerance to ingested antigens, whether by
passive (anergy) or active (suppressor cells)
processes, are poorly understood and may be
crucial to understanding what makes a pro-
tein allergenic and what makes an individual
susceptible. The contributions of in utero
exposure, gut immaturity, and exposure via
breast milk to children’s risk of sensitization
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Genetically Modiﬁed Foods | Mini-Monographalso need to be determined. Studies (possibly
using transgenic mice) are needed to assess
the heritable factors that contribute to suscep-
tibility to food allergy. Epidemiology is
needed to determine whether the incidence of
food allergy in the industrialized world, like
the incidence of other types of allergic disease,
is increasing.
The natural history of non–IgE-mediated
food allergies (although somewhat beyond
the scope of this current workshop) was also
considered an important long-term research
need. Questions were raised as to whether
certain foods were associated with this type
of allergy and whether IgE is a reasonable
surrogate marker in this instance or if other
biomarkers would be more appropriate. The
context in which food is presented, including
the matrix, concomitant infections, and other
sources of gut inflammation, also deserves
further attention with respect to both IgE-
and non–IgE-mediated food allergies. Basic
mechanistic research needs are summarized
in Table 1.
Recommendations
In summary, there was consensus that research
should progress quickly in the area of hazard
identification to improve or replace the
FAO/WHO decision tree. Support was partic-
ularly strong for the development, standardiza-
tion, and validation of appropriate animal
model(s) for this purpose. It was also generally
agreed that there is much we do not know
about the development of food allergies, and
that more basic research in this area would help
us to control the risks more effectively and efﬁ-
ciently. More work is needed than any one
funding organization is likely to be able to sup-
port. Therefore, it is recommended that there
be signiﬁcant coordination between these orga-
nizations and an integrated approach to tack-
ling this problem. Open and free exchange of
information as it becomes available is needed
to facilitate these research endeavors.
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Table 1. Summary of research needs.
Hazard identiﬁcation
Development, evaluation, and validation of animal models
Establishment of clinically well-deﬁned banks of human serum containing antibodies to allergens
Improved human skin test technology
Identiﬁcation, puriﬁcation, and banking of both known protein allergens and proteins believed not to be allergenic
A systemic approach to recording adverse events (case studies)
Deﬁnition of relative potency and thresholds for sensitization and the elicitation of allergic reactions
Development, reﬁnement, standardization, and validation of test protocols
Basic mechanistic
Development of animal models of allergic disease
Studies of the qualitative and quantitative relationships between antigen-speciﬁc IgE and overt disease
Investigation of the inﬂuence of route, duration, timing, and nature of exposure on the development of sensitization
Studies of the factors that contribute to susceptibility to food allergy
Investigation of the mechanisms underlying food allergy
Investigation of potential windows of vulnerability during development
Identiﬁcation of unique situations that cause children or other individuals to be at greater risk
Epidemiology to establish the incidence of food allergy and whether it is changing
Studies of the potential role of non–IgE-mediated reactions in food allergy
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